Physician profile
Leonard I Ganz
NPI 1225083405
$42,052.60
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $7,209 · 2021: $2,272 · 2022: $632 · 2023: $40.32 · 2024: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19,538.26 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $6,644.99 | 2019-2020 | |
| Abbott Laboratories | $6,084.66 | 2019-2022 | |
| Lundbeck LLC | $3,387.61 | 2020 | |
| Boston Scientific Corporation | $1,732.82 | 2019-2024 | |
| Medtronic, INC. | $975.37 | 2021 | |
| Janssen Pharmaceuticals, INC | $953.80 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $596.07 | 2019-2022 | |
| Amgen INC. | $397.04 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $355.33 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $324.36 | 2019-2022 | |
| Medtronic Vascular, INC. | $224.35 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $142.44 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $128.71 | 2022 | |
| Genzyme Corporation | $125.00 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $99.99 | 2022 | |
| Portola Pharmaceuticals, LLC | $88.70 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.04 | 2021 | |
| Mindray Ds USA, INC. | $40.32 | 2023 | A7 Anesthesia System |
| Amarin Pharma, INC. | $29.36 | 2019-2020 | |
| Covidien LP | $25.44 | 2019 | |
| Novo Nordisk INC | $23.60 | 2021 | |
| Ethicon US, LLC | $21.89 | 2019 | |
| Cvrx, INC. | $14.64 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.39 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.57 | 2019 | |
| Cardiofocus, INC. | $6.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Ganz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.